Another study on 96 fresh frozen ovarian cancer tissues obtained from chemotherapy-naïve patients and patients after neoadjuvant chemotherapy was performed using a tailored NanoString-based Pancancer Pathway Panel of 19 HR genes and showed a correlation between over-expression of C11osf30, NBN, FANCF, FANCC, FANCB, RAD50 and improved outcome in chemotherapy-naïve patients. This evidence concerns the gene RAD50 and ovarian carcinoma.